17 Jan 2018 07:00
Sinclair Pharma plc
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
London, 17 January 2018 Sinclair Pharma plc (AIM:SPH.L) ("Sinclair" or the "Group"), the international aesthetics company, was advised on 16 January 2018, that on that day, Jeff Thompson, Non-Executive Director, acquired 200,000 ordinary shares of 1p each ("Ordinary Shares") in the Group at an average price of 23.1p per Ordinary Share.
Following these purchases, Jeff Thompson's total beneficial interest is 350,000 Ordinary Shares, 0.07% of the issued share capital of the Group.
For further information please contact:
Sinclair Pharma plc | Tel: +44 (0) 20 7467 6920 |
Chris Spooner | |
Alan Olby | |
Andy Crane |
Peel Hunt LLP (NOMAD and Joint Broker) | Tel: +44 (0) 20 7418 8900 |
James Steel | |
Oliver Jackson |
RBC Capital Markets (Joint Broker) | Tel: +44 (0) 20 7653 4000 |
Marcus Jackson | |
Laura White | |
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
a. | Name | Jeff Thompson | ||||
2. | Reason for the notification | |||||
a. | Position/status | Non-Executive Director | ||||
b. | Initial notification /Amendment | Initial Announcement | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a. | Name | Sinclair Pharma plc | ||||
b. | LEI | 213800BNMD7JVMHW1772 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a. | Description of the Financial instrument, type of instrument Identification code | Ordinary Shares of 1 pence each in Sinclair Pharma plc
GB0033856740 | ||||
b. | Nature of the transaction | Purchase
| ||||
c. | Price(s) and volume(s) |
| ||||
d. | Aggregated information · Aggregated volume · Price
|
N/A
| ||||
e. | Date of the transaction | 2018-01-16 | ||||
f. | Place of the transaction | London Stock Exchange, AIM
| ||||
Sinclair Pharma (SPH)